Optimization of 4D-CT in the Diagnostic Workup of Tumors of the Pancreas

Optimization of 4D-CT in the Diagnostic Workup of Tumors of the Pancreas - CT perfusion in pancreatic tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37591

Enrollment

Registered

2012-01-09

Start date

2011-12-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreas tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a suspected tumor in the head of the pancreas. Older than 18 years.

Exclusion criteria

Exclusion criteria: Previous surgery of the pancreas Previous chemoradiation therapy of the pancreas Transpapillary endoprosthesis in situ Patients with active hepatitis or other hepatic diseases that may cause jaundice Informed consent not obtained

Design outcomes

Primary

Measure	Time frame
1. Radiation dose for the combined diagnostic and perfusion scan 2. Detection of the pancreas tumor with a perfusion scan compared to a regular diagnostic scan 3. Detection of liver metastases with a perfusion scan compared to a regular diagnostic scan	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results